{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:31:02Z","timestamp":1778887862260,"version":"3.51.4"},"publisher-location":"Singapore","reference-count":168,"publisher":"Springer Nature Singapore","isbn-type":[{"value":"9789819744015","type":"print"},{"value":"9789819744022","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-981-97-4402-2_1","type":"book-chapter","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T02:02:35Z","timestamp":1726106555000},"page":"3-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endocrinological Treatment Targets for Depressive Disorder"],"prefix":"10.1007","author":[{"given":"Seoyoung","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Ku","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"issue":"19","key":"1_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911952","volume":"23","author":"M Alemany","year":"2022","unstructured":"Alemany M (2022) The roles of androgens in humans: biology, metabolic regulation and health. Int J Mol Sci 23(19):11952","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1_CR2","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1176\/appi.ajp.158.10.1617","volume":"158","author":"LL Altshuler","year":"2001","unstructured":"Altshuler LL, Bauer M, Frye MA, Gitlin MJ, Mintz J, Szuba MP et al (2001) Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry 158(10):1617\u20131622","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1_CR3","first-page":"19","volume":"26","author":"HR Amanatkar","year":"2014","unstructured":"Amanatkar HR, Chibnall JT, Seo BW, Manepalli JN, Grossberg GT (2014) Impact of exogenous testosterone on mood: a systematic review and meta-analysis of randomized placebo-controlled trials. Ann Clin Psychiatry 26(1):19\u201332","journal-title":"Ann Clin Psychiatry"},{"key":"1_CR4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787","volume-title":"Diagnostic and statistical manual of mental disorders. Fifth edition, text revision ed","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association (2022) Diagnostic and statistical manual of mental disorders. Fifth edition, text revision ed. American Psychiatric Association, Washington, DC"},{"issue":"3","key":"1_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.psyneuen.2010.03.007","volume":"36","author":"C Anacker","year":"2011","unstructured":"Anacker C, Zunszain PA, Carvalho LA, Pariante CM (2011) The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 36(3):415\u2013425","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"1_CR6","doi-asserted-by":"publisher","first-page":"101561","DOI":"10.1016\/j.beem.2021.101561","volume":"35","author":"E Armeni","year":"2021","unstructured":"Armeni E, Paschou SA, Goulis DG, Lambrinoudaki I (2021) Hormone therapy regimens for managing the menopause and premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab 35(6):101561","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"1_CR7","first-page":"957","volume":"111","author":"BM Arnold","year":"1974","unstructured":"Arnold BM, Casal G, Higgins HP (1974) Apathetic thyrotoxicosis. Can Med Assoc J 111(9):957\u2013958","journal-title":"Can Med Assoc J"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"105426","DOI":"10.1016\/j.psyneuen.2021.105426","volume":"133","author":"T B\u00e4ckstr\u00f6m","year":"2021","unstructured":"B\u00e4ckstr\u00f6m T, Ekberg K, Hirschberg AL, Bixo M, Epperson CN, Briggs P et al (2021) A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder. Psychoneuroendocrinology 133:105426","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"1_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1210\/jcem-71-3-650","volume":"71","author":"L Bartalena","year":"1990","unstructured":"Bartalena L, Placidi GF, Martino E, Falcone M, Pellegrini L, Dell\u2019Osso L et al (1990) Nocturnal serum thyrotropin (TSH) surge and the TSH response to TSH-releasing hormone: dissociated behavior in untreated depressives. J Clin Endocrinol Metab 71(3):650\u2013655","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1_CR10","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1007\/s40618-021-01600-w","volume":"44","author":"M Bauer","year":"2021","unstructured":"Bauer M, Whybrow PC (2021) Role of thyroid hormone therapy in depressive disorders. J Endocrinol Investig 44(11):2341\u20132347","journal-title":"J Endocrinol Investig"},{"issue":"10","key":"1_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1365-2826.2008.01774.x","volume":"20","author":"M Bauer","year":"2008","unstructured":"Bauer M, Goetz T, Glenn T, Whybrow PC (2008) The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 20(10):1101\u20131114","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"1_CR12","doi-asserted-by":"publisher","first-page":"351.e1","DOI":"10.1016\/j.ajog.2008.04.048","volume":"199","author":"AB Berenson","year":"2008","unstructured":"Berenson AB, Odom SD, Breitkopf CR, Rahman M (2008) Physiologic and psychologic symptoms associated with use of injectable contraception and 20 \u03bcg oral contraceptive pills. Am J Obstet Gynecol 199(4):351.e1\u2013351.e12","journal-title":"Am J Obstet Gynecol"},{"key":"1_CR13","volume-title":"Endotext","author":"J Bernal","year":"2000","unstructured":"Bernal J (2000) Thyroid hormones in brain development and function. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E et al (eds) Endotext. MDText.com, South Dartmouth, MA"},{"issue":"3","key":"1_CR14","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1530\/JOE-22-0189","volume":"255","author":"J Bernal","year":"2022","unstructured":"Bernal J, Morte B, Diez D (2022) Thyroid hormone regulators in human cerebral cortex development. J Endocrinol 255(3):R27\u2013R36","journal-title":"J Endocrinol"},{"issue":"5","key":"1_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1176\/appi.ajp.2008.07071199","volume":"165","author":"B Binneman","year":"2008","unstructured":"Binneman B, Feltner D, Kolluri S, Shi Y, Qiu R, Stiger T (2008) A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression. Am J Psychiatry 165(5):617\u2013620","journal-title":"Am J Psychiatry"},{"key":"1_CR16","volume-title":"Biogen and Sage therapeutics share update on FDA advisory committee for zuranolone","author":"Biogen","year":"2023","unstructured":"Biogen (2023) Biogen and Sage therapeutics share update on FDA advisory committee for zuranolone. Biogen, Cambridge, MA"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.psyneuen.2017.02.031","volume":"80","author":"M Bixo","year":"2017","unstructured":"Bixo M, Ekberg K, Poromaa IS, Hirschberg AL, Jonasson AF, Andr\u00e9en L et al (2017) Treatment of premenstrual dysphoric disorder with the GABA(A) receptor modulating steroid antagonist Sepranolone (UC1010)\u2014a randomized controlled trial. Psychoneuroendocrinology 80:46\u201355","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"1_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biopsych.2018.01.008","volume":"84","author":"TS Block","year":"2018","unstructured":"Block TS, Kushner H, Kalin N, Nelson C, Belanoff J, Schatzberg A (2018) Combined analysis of mifepristone for psychotic depression: plasma levels associated with clinical response. Biol Psychiatry 84(1):46\u201354","journal-title":"Biol Psychiatry"},{"issue":"12","key":"1_CR19","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamapsychiatry.2021.2506","volume":"78","author":"H Bode","year":"2021","unstructured":"Bode H, Ivens B, Bschor T, Schwarzer G, Henssler J, Baethge C (2021) Association of hypothyroidism and clinical depression: a systematic review and meta-analysis. JAMA Psychiatry 78(12):1375\u20131383","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"1_CR20","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","volume":"60","author":"N Bradley","year":"2009","unstructured":"Bradley N, Gaynes MD, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ (2009) What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 60(11):1439\u20131445","journal-title":"Psychiatr Serv"},{"issue":"3","key":"1_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/YCO.0000000000000699","volume":"34","author":"BA Brand","year":"2021","unstructured":"Brand BA, de Boer JN, Sommer IEC (2021) Estrogens in schizophrenia: progress, current challenges and opportunities. Curr Opin Psychiatry 34(3):228\u2013237","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"1_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1034\/j.1399-5618.2001.030103.x","volume":"3","author":"ES Brown","year":"2001","unstructured":"Brown ES, Bobadilla L, Rush AJ (2001) Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review. Bipolar Disord 3(1):23\u201329","journal-title":"Bipolar Disord"},{"issue":"2","key":"1_CR23","volume":"2","author":"JVE Brown","year":"2021","unstructured":"Brown JVE, Wilson CA, Ayre K, Robertson L, South E, Molyneaux E et al (2021) Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev 2(2):CD013560","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"1_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214138","volume":"23","author":"C Bulletti","year":"2022","unstructured":"Bulletti C, Bulletti FM, Sciorio R, Guido M (2022) Progesterone: the key factor of the beginning of life. Int J Mol Sci 23(22):14138","journal-title":"Int J Mol Sci"},{"key":"1_CR25","volume-title":"StatPearls","author":"M Campbell","year":"2023","unstructured":"Campbell M, Jialal I (2023) Physiology, endocrine hormones. In: StatPearls. StatPearls, Treasure Island, FL. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538498\/"},{"key":"1_CR26","unstructured":"Center GR (2017) A study of the effects of a new antidepressant treatment (GSK561679) in females with major depressive disorder 2017. https:\/\/clinicaltrials.gov\/study\/NCT00733980?tab=results"},{"issue":"1","key":"1_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-022-00357-7","volume":"8","author":"L Chaker","year":"2022","unstructured":"Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP (2022) Hypothyroidism. Nat Rev Dis Primers 8(1):30","journal-title":"Nat Rev Dis Primers"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"117955142199410","DOI":"10.1177\/1179551421994102","volume":"14","author":"AY Chang","year":"2021","unstructured":"Chang AY, Mirfakhraee S, King EE, Mercado JU, Donegan DM, Yuen KC (2021) Mifepristone as bridge or adjunct therapy in the management of challenging Cushing disease cases. Clin Med Insights Endocrinol Diabetes 14:1179551421994102","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"3","key":"1_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/15622975.2021.1939154","volume":"23","author":"G Cheiran Pereira","year":"2022","unstructured":"Cheiran Pereira G, Piton E, Moreira dos Santos B, Ramanzini LG, Muniz Camargo LF, Menezes da Silva R et al (2022) Microglia and HPA axis in depression: an overview of participation and relationship. World J Biol Psychiatry 23(3):165\u2013182","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"1_CR30","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22m14445","volume":"84","author":"AH Clayton","year":"2023","unstructured":"Clayton AH, Lasser R, Nandy I, Sankoh AJ, Jonas J, Kanes SJ (2023a) Zuranolone in major depressive disorder: results from mountain\u2014a phase 3, multicenter, double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 84(2):22m14445","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"1_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1176\/appi.ajp.20220459","volume":"180","author":"AH Clayton","year":"2023","unstructured":"Clayton AH, Lasser R, Parikh SV, Iosifescu DV, Jung JA, Kotecha M et al (2023b) Zuranolone for the treatment of adults with major depressive disorder: a randomized, placebo-controlled phase 3 trial. Am J Psychiatr 180(9):676\u2013684","journal-title":"Am J Psychiatr"},{"issue":"3","key":"1_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1176\/appi.ajp.2020.20030286","volume":"178","author":"E Comasco","year":"2021","unstructured":"Comasco E, Kallner HK, Bixo M, Hirschberg AL, Nyback S, de Grauw H et al (2021) Ulipristal acetate for treatment of premenstrual dysphoric disorder: a proof-of-concept randomized controlled trial. Am J Psychiatr 178(3):256\u2013265","journal-title":"Am J Psychiatr"},{"issue":"3","key":"1_CR33","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1152\/physrev.00018.2016","volume":"97","author":"PS Cooke","year":"2017","unstructured":"Cooke PS, Nanjappa MK, Ko C, Prins GS, Hess RA (2017) Estrogens in male physiology. Physiol Rev 97(3):995\u20131043","journal-title":"Physiol Rev"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.psychres.2018.06.005","volume":"268","author":"AB de Carvalho","year":"2018","unstructured":"de Carvalho AB, Cardoso TA, Mondin TC, da Silva RA, Souza LDM, Magalh\u00e3es P et al (2018) Prevalence and factors associated with premenstrual Dysphoric disorder: a community sample of young adult women. Psychiatry Res 268:42\u201345","journal-title":"Psychiatry Res"},{"issue":"8","key":"1_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12379","volume":"28","author":"ER de Kloet","year":"2016","unstructured":"de Kloet ER, Otte C, Kumsta R, Kok L, Hillegers MHJ, Hasselmann H et al (2016) Stress and depression: a crucial role of the mineralocorticoid receptor. J Neuroendocrinol 28(8):e12379","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"1_CR36","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2021.64","volume":"7","author":"AE de Wit","year":"2021","unstructured":"de Wit AE, de Vries YA, de Boer MK, Scheper C, Fokkema AA, Schoevers RA et al (2021) Hormonal contraceptive use and depressive symptoms: systematic review and network meta-analysis of randomised trials. BJPsych Open 7(4):e110","journal-title":"BJPsych Open"},{"issue":"6","key":"1_CR37","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jpsychires.2013.02.010","volume":"47","author":"KM Deligiannidis","year":"2013","unstructured":"Deligiannidis KM, Sikoglu EM, Shaffer SA, Frederick B, Svenson AE, Kopoyan A et al (2013) GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J Psychiatr Res 47(6):816\u2013828","journal-title":"J Psychiatr Res"},{"issue":"9","key":"1_CR38","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jamapsychiatry.2021.1559","volume":"78","author":"KM Deligiannidis","year":"2021","unstructured":"Deligiannidis KM, Meltzer-Brody S, Gunduz-Bruce H, Doherty J, Jonas J, Li S et al (2021) Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial. JAMA Psychiatry 78(9):951\u2013959","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"1_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1176\/appi.ajp.20220785","volume":"180","author":"KM Deligiannidis","year":"2023","unstructured":"Deligiannidis KM, Meltzer-Brody S, Maximos B, Peeper EQ, Freeman M, Lasser R et al (2023a) Zuranolone for the treatment of postpartum depression. Am J Psychiatry 180(9):668\u2013675","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1_CR40","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22m14475","volume":"84","author":"KM Deligiannidis","year":"2023","unstructured":"Deligiannidis KM, Citrome L, Huang MY, Acaster S, Fridman M, Bonthapally V et al (2023b) Effect of zuranolone on concurrent anxiety and insomnia symptoms in women with postpartum depression. J Clin Psychiatry 84(1):22m14475","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"1_CR41","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1176\/appi.ajp.2020.19080844","volume":"177","author":"LE Dichtel","year":"2020","unstructured":"Dichtel LE, Carpenter LL, Nyer M, Mischoulon D, Kimball A, Deckersbach T et al (2020) Low-dose testosterone augmentation for antidepressant-resistant major depressive disorder in women: an 8-week randomized placebo-controlled study. Am J Psychiatry 177(10):965\u2013973","journal-title":"Am J Psychiatry"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"732157","DOI":"10.3389\/fphar.2021.732157","volume":"12","author":"Y Ding","year":"2021","unstructured":"Ding Y, Wei Z, Yan H, Guo W (2021) Efficacy of treatments targeting hypothalamic-pituitary-adrenal systems for major depressive disorder: a meta-analysis. Front Pharmacol 12:732157","journal-title":"Front Pharmacol"},{"issue":"2","key":"1_CR43","first-page":"106","volume":"8","author":"A Direkvand-Moghadam","year":"2014","unstructured":"Direkvand-Moghadam A, Khosravi S, Delpisheh A, Sattar K (2014) Epidemiology of premenstrual syndrome (PMS)\u2014a systematic review and meta-analysis study. J Clin Diagn Res 8(2):106\u2013109","journal-title":"J Clin Diagn Res"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.euroneuro.2022.09.002","volume":"64","author":"S Dodd","year":"2022","unstructured":"Dodd S, Sominsky L, Siskind D, Bortolasci CC, Carvalho AF, Maes M et al (2022) The role of metformin as a treatment for neuropsychiatric illness. Eur Neuropsychopharmacol 64:32\u201343","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"1_CR45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.34172\/hpp.2021.20","volume":"11","author":"A Dutta","year":"2021","unstructured":"Dutta A, Sharma A (2021) Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in India: a systematic review and meta-analysis. Health Promot Perspect 11(2):161\u2013170","journal-title":"Health Promot Perspect"},{"issue":"13","key":"1_CR46","first-page":"166","volume":"3","author":"F Duval","year":"2018","unstructured":"Duval F, Mokrani MC (2018) Thyroid axis activity in depression. Ann Thyroid Res 3(13):166\u2013171","journal-title":"Ann Thyroid Res"},{"issue":"5","key":"1_CR47","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/archpsyc.1990.01810170043007","volume":"47","author":"F Duval","year":"1990","unstructured":"Duval F, Macher JP, Mokrani MC (1990) Difference between evening and morning thyrotropin responses to protirelin in major depressive episode. Arch Gen Psychiatry 47(5):443\u2013448","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"1_CR48","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/brainsci12050621","volume":"12","author":"F Duval","year":"2022","unstructured":"Duval F, Mokrani MC, Danila V, Erb A, Gonzalez Lopera F, Tomsa M (2022) Dopamine function and hypothalamic-pituitary-thyroid axis activity in major depressed patients with suicidal behavior. Brain Sci 12(5):621","journal-title":"Brain Sci"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"105079","DOI":"10.1016\/j.bioorg.2021.105079","volume":"114","author":"HR Elgiushy","year":"2021","unstructured":"Elgiushy HR, Abou-Taleb NA, Holz GG, Chepurny OG, Pirmettis I, Kakabakos S et al (2021) Synthesis, in vitro biological investigation, and molecular dynamics simulations of thiazolopyrimidine based compounds as corticotrophin releasing factor receptor-1 antagonists. Bioorg Chem 114:105079","journal-title":"Bioorg Chem"},{"issue":"3","key":"1_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00213-006-0313-7","volume":"186","author":"CN Epperson","year":"2006","unstructured":"Epperson CN, Gueorguieva R, Czarkowski KA, Stiklus S, Sellers E, Krystal JH et al (2006) Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology 186(3):425\u2013433","journal-title":"Psychopharmacology"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jad.2022.09.143","volume":"320","author":"CN Epperson","year":"2023","unstructured":"Epperson CN, Rubinow DR, Meltzer-Brody S, Deligiannidis KM, Riesenberg R, Krystal AD et al (2023) Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program. J Affect Disord 320:353\u2013359","journal-title":"J Affect Disord"},{"issue":"3","key":"1_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0165-1781(81)90077-9","volume":"5","author":"I Extein","year":"1981","unstructured":"Extein I, Pottash ALC, Gold MS (1981) The thyrotropin-releasing hormone test in the diagnosis of unipolar depression. Psychiatry Res 5(3):311\u2013316","journal-title":"Psychiatry Res"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"135849","DOI":"10.1016\/j.neulet.2021.135849","volume":"753","author":"L Fester","year":"2021","unstructured":"Fester L, Rune GM (2021) Sex neurosteroids: hormones made by the brain for the brain. Neurosci Lett 753:135849","journal-title":"Neurosci Lett"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"100792","DOI":"10.1016\/j.yfrne.2019.100792","volume":"55","author":"S Fischer","year":"2019","unstructured":"Fischer S, Ehlert U, Amiel CR (2019) Hormones of the hypothalamic-pituitary-gonadal (HPG) axis in male depressive disorders\u2014a systematic review and meta-analysis. Front Neuroendocrinol 55:100792","journal-title":"Front Neuroendocrinol"},{"issue":"11","key":"1_CR55","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S2213-8587(19)30313-4","volume":"7","author":"M Fleseriu","year":"2019","unstructured":"Fleseriu M, Pivonello R, Elenkova A, Salvatori R, Auchus RJ, Feelders RA et al (2019) Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing\u2019s syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial. Lancet Diabetes Endocrinol 7(11):855\u2013865","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-244X-4-6","volume":"4","author":"KN Fountoulakis","year":"2004","unstructured":"Fountoulakis KN, Iacovides A, Grammaticos P, St Kaprinis G, Bech P (2004) Thyroid function in clinical subtypes of major depression: an exploratory study. BMC Psychiatry 4:6","journal-title":"BMC Psychiatry"},{"issue":"4","key":"1_CR57","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/archpsyc.63.4.375","volume":"63","author":"EW Freeman","year":"2006","unstructured":"Freeman EW, Sammel MD, Lin H, Nelson DB (2006) Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63(4):375\u2013382","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"1_CR58","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.contraception.2011.09.010","volume":"85","author":"EW Freeman","year":"2012","unstructured":"Freeman EW, Halbreich U, Grubb GS, Rapkin AJ, Skouby SO, Smith L et al (2012) An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg\/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception 85(5):437\u2013445","journal-title":"Contraception"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"1140796","DOI":"10.3389\/fpsyt.2023.1140796","volume":"14","author":"Q Gao","year":"2023","unstructured":"Gao Q, Sun W, Wang YR, Li ZF, Zhao F, Geng XW et al (2023) Role of allopregnanolone-mediated \u03b3-aminobutyric acid a receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: toward precise targets for translational medicine and drug development. Front Psych 14:1140796","journal-title":"Front Psych"},{"issue":"3","key":"1_CR60","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40801-023-00372-4","volume":"10","author":"S Garafola","year":"2023","unstructured":"Garafola S, Shiferaw E, Dev V (2023) Safety of brexanolone in adults with postpartum depression: postmarketing surveillance data. Drugs Real World Outcomes 10(3):351\u2013356","journal-title":"Drugs Real World Outcomes"},{"issue":"1","key":"1_CR61","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11102-020-01103-6","volume":"24","author":"EB Geer","year":"2021","unstructured":"Geer EB, Salvatori R, Elenkova A, Fleseriu M, Pivonello R, Witek P et al (2021) Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing\u2019s syndrome. Pituitary 24(1):104\u2013115","journal-title":"Pituitary"},{"issue":"2","key":"1_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000135710","volume":"88","author":"EJ Giltay","year":"2008","unstructured":"Giltay EJ, Bunck MC, Gooren LJ, Zitman FG, Diamant M, Teerlink T (2008) Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects. Neuroendocrinology 88(2):103\u2013110","journal-title":"Neuroendocrinology"},{"issue":"4","key":"1_CR63","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jagp.2016.12.014","volume":"25","author":"EJ Giltay","year":"2017","unstructured":"Giltay EJ, van der Mast RC, Lauwen E, Heijboer AC, de Waal MWM, Comijs HC (2017) Plasma testosterone and the course of major depressive disorder in older men and women. Am J Geriatr Psychiatry 25(4):425\u2013437","journal-title":"Am J Geriatr Psychiatry"},{"issue":"10","key":"1_CR64","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1056\/NEJMoa1815981","volume":"381","author":"H Gunduz-Bruce","year":"2019","unstructured":"Gunduz-Bruce H, Silber C, Kaul I, Rothschild AJ, Riesenberg R, Sankoh AJ et al (2019) Trial of SAGE-217 in patients with major depressive disorder. N Engl J Med 381(10):903\u2013911","journal-title":"N Engl J Med"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"590648","DOI":"10.1155\/2012\/590648","volume":"2012","author":"MP Hage","year":"2012","unstructured":"Hage MP, Azar ST (2012) The link between thyroid function and depression. J Thyroid Res 2012:590648","journal-title":"J Thyroid Res"},{"issue":"Suppl 3","key":"1_CR66","first-page":"1","volume":"28","author":"U Halbreich","year":"2003","unstructured":"Halbreich U, Borenstein J, Pearlstein T, Kahn LS (2003) The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD). Psychoneuroendocrinology 28(Suppl 3):1\u201323","journal-title":"Psychoneuroendocrinology"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"105168","DOI":"10.1016\/j.neubiorev.2023.105168","volume":"149","author":"L Hantsoo","year":"2023","unstructured":"Hantsoo L, Payne JL (2023) Towards understanding the biology of premenstrual dysphoric disorder: from genes to GABA. Neurosci Biobehav Rev 149:105168","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"1_CR68","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1210\/jc.2011-3362","volume":"97","author":"SD Harlow","year":"2012","unstructured":"Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW et al (2012) Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 97(4):1159\u20131168","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1_CR69","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s11154-022-09767-0","volume":"23","author":"RL Hauger","year":"2022","unstructured":"Hauger RL, Saelzler UG, Pagadala MS, Panizzon MS (2022) The role of testosterone, the androgen receptor, and hypothalamic-pituitary-gonadal axis in depression in ageing men. Rev Endocr Metab Disord 23(6):1259\u20131273","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"1_CR70","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0022-3956(03)00076-1","volume":"38","author":"K Held","year":"2004","unstructured":"Held K, K\u00fcnzel H, Ising M, Schmid DA, Zobel A, Murck H et al (2004) Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression. J Psychiatr Res 38(2):129\u2013136","journal-title":"J Psychiatr Res"},{"issue":"3","key":"1_CR71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000358838","volume":"69","author":"C Hellgren","year":"2014","unstructured":"Hellgren C, \u00c5kerud H, Skalkidou A, B\u00e4ckstr\u00f6m T, Sundstr\u00f6m-Poromaa I (2014) Low serum allopregnanolone is associated with symptoms of depression in late pregnancy. Neuropsychobiology 69(3):147\u2013153","journal-title":"Neuropsychobiology"},{"key":"1_CR72","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.maturitas.2022.11.001","volume":"168","author":"C Hemachandra","year":"2023","unstructured":"Hemachandra C, Islam RM, Bell RJ, Sultana F, Davis SR (2023) The association between testosterone and depression in postmenopausal women: a systematic review of observational studies. Maturitas 168:62\u201370","journal-title":"Maturitas"},{"issue":"2","key":"1_CR73","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0033-3182(98)71355-6","volume":"39","author":"V Hendrick","year":"1998","unstructured":"Hendrick V, Altshuler LL, Suri R (1998) Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics 39(2):93\u2013101","journal-title":"Psychosomatics"},{"issue":"2","key":"1_CR74","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ejphar.2007.12.032","volume":"583","author":"F Holsboer","year":"2008","unstructured":"Holsboer F, Ising M (2008) Central CRH system in depression and anxiety\u2014evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583(2):350\u2013357","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"1_CR75","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.4088\/JCP.v66n0812","volume":"66","author":"DV Iosifescu","year":"2005","unstructured":"Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL et al (2005) An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. J Clin Psychiatry 66(8):1038\u20131042","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"1_CR76","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/archpsyc.61.12.1235","volume":"61","author":"H Jahn","year":"2004","unstructured":"Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K (2004) Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry 61(12):1235\u20131244","journal-title":"Arch Gen Psychiatry"},{"key":"1_CR77","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1515\/med-2019-0008","volume":"14","author":"N Jucevi\u010di\u016bt\u0117","year":"2019","unstructured":"Jucevi\u010di\u016bt\u0117 N, \u017dilaitien\u0117 B, Aniulien\u0117 R, Vanagien\u0117 V (2019) The link between thyroid autoimmunity, depression and bipolar disorder. Open Med (Wars) 14:52\u201358","journal-title":"Open Med (Wars)"},{"issue":"19","key":"1_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191912507","volume":"19","author":"K Karolczak","year":"2022","unstructured":"Karolczak K, Kostanek J, Soltysik B, Konieczna L, Baczek T, Kostka T et al (2022) Relationships between plasma concentrations of testosterone and dihydrotestosterone and geriatric depression scale scores in men and women aged 60\u201365 years-a multivariate approach with the use of Quade\u2019s test. Int J Environ Res Public Health 19(19):12507","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"1_CR79","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","volume":"61","author":"SH Kennedy","year":"2016","unstructured":"Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P et al (2016) Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry 61(9):540\u2013560","journal-title":"Can J Psychiatry"},{"issue":"2","key":"1_CR80","first-page":"65","volume":"5","author":"F Kheirkhah","year":"2014","unstructured":"Kheirkhah F, Hosseini SR, Hosseini SF, Ghasemi N, Bijani A, Cumming RG (2014) Relationship between testosterone levels and depressive symptoms in older men in Amirkola, Iran. Caspian J Intern Med 5(2):65\u201370","journal-title":"Caspian J Intern Med"},{"issue":"11","key":"1_CR81","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11920-021-01286-0","volume":"23","author":"C Kuehner","year":"2021","unstructured":"Kuehner C, Nayman S (2021) Premenstrual exacerbations of mood disorders: findings and knowledge gaps. Curr Psychiatry Rep 23(11):78","journal-title":"Curr Psychiatry Rep"},{"issue":"2","key":"1_CR82","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00737-019-00959-3","volume":"23","author":"MB Lascurain","year":"2020","unstructured":"Lascurain MB, Camu\u00f1as-Palac\u00edn A, Thomas N, Breadon C, Gavrilidis E, Hudaib AR et al (2020) Improvement in depression with oestrogen treatment in women with schizophrenia. Arch Womens Ment Health 23(2):149\u2013154","journal-title":"Arch Womens Ment Health"},{"key":"1_CR83","first-page":"55","volume-title":"Handbook of clinical neurology","author":"C Leistner","year":"2020","unstructured":"Leistner C, Menke A (2020) Hypothalamic\u2013pituitary\u2013adrenal axis and stress. In: Lanzenberger R, Kranz GS, Savic I (eds) Handbook of clinical neurology, vol 175. Elsevier, London, pp 55\u201364"},{"issue":"3","key":"1_CR84","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00737-019-00991-3","volume":"23","author":"HJ Li","year":"2020","unstructured":"Li HJ, Martinez PE, Li X, Schenkel LA, Nieman LK, Rubinow DR et al (2020) Transdermal estradiol for postpartum depression: results from a pilot randomized, double-blind, placebo-controlled study. Arch Womens Ment Health 23(3):401\u2013412","journal-title":"Arch Womens Ment Health"},{"key":"1_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1204842","volume":"14","author":"I Lieber","year":"2023","unstructured":"Lieber I, Van Der Feltz-Cornelis CM, Razvi S, Moriarty AS, Wilkes S, Ott M et al (2023) Treating subclinical hypothyroidism in individuals with or without mental health problems\u2014a Delphi based expert consensus study in two countries. Front Endocrinol (Lausanne) 14:1204842","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102308","volume":"66","author":"Y-W Lin","year":"2023","unstructured":"Lin Y-W, Tu Y-K, Hung K-C, Liang C-S, Tseng P-T, Lin P-Y et al (2023) Efficacy and safety of zuranolone in major depressive disorder: a meta-analysis of factor effect and dose-response analyses. EClinicalMedicine 66:102308","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1_CR87","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12888-018-2006-2","volume":"19","author":"HH Loh","year":"2019","unstructured":"Loh HH, Lim LL, Yee A, Loh HS (2019) Association between subclinical hypothyroidism and depression: an updated systematic review and meta-analysis. BMC Psychiatry 19(1):12","journal-title":"BMC Psychiatry"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"104420","DOI":"10.1016\/j.psyneuen.2019.104420","volume":"110","author":"G Lombardo","year":"2019","unstructured":"Lombardo G, Enache D, Gianotti L, Schatzberg AF, Young AH, Pariante CM et al (2019) Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: a meta-analysis. Psychoneuroendocrinology 110:104420","journal-title":"Psychoneuroendocrinology"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.psyneuen.2016.11.033","volume":"76","author":"C Lundin","year":"2017","unstructured":"Lundin C, Danielsson KG, Bixo M, Moby L, Bengtsdotter H, Jawad I et al (2017) Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-a double-blind, placebo-controlled randomized trial. Psychoneuroendocrinology 76:135\u2013143","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"1_CR90","volume":"6","author":"S Ma","year":"2023","unstructured":"Ma S, Song SJ (2023) Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 6(6):CD006586","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1_CR91","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1042\/EBC20200162","volume":"65","author":"S Maioli","year":"2021","unstructured":"Maioli S, Leander K, Nilsson P, Nalvarte I (2021) Estrogen receptors and the aging brain. Essays Biochem 65(6):913\u2013925","journal-title":"Essays Biochem"},{"issue":"10","key":"1_CR92","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/GME.0000000000001174","volume":"25","author":"PM Maki","year":"2018","unstructured":"Maki PM, Kornstein SG, Joffe H, Bromberger JT, Freeman EW, Athappilly G et al (2018) Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause 25(10):1069\u20131085","journal-title":"Menopause"},{"issue":"6","key":"1_CR93","volume":"2013","author":"J Marjoribanks","year":"2013","unstructured":"Marjoribanks J, Brown J, O\u2019Brien PM, Wyatt K (2013) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2013(6):CD001396","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1_CR94","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.contraception.2010.10.010","volume":"84","author":"J Marr","year":"2011","unstructured":"Marr J, Niknian M, Shulman LP, Lynen R (2011) Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24\/4 regimen. Contraception 84(1):81\u201386","journal-title":"Contraception"},{"issue":"4","key":"1_CR95","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/npp.2015.246","volume":"41","author":"PE Martinez","year":"2016","unstructured":"Martinez PE, Rubinow DR, Nieman LK, Koziol DE, Morrow AL, Schiller CE et al (2016) 5\u03b1-Reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder. Neuropsychopharmacology 41(4):1093\u20131102","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1_CR96","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2215-0366(15)00436-8","volume":"3","author":"RH McAllister-Williams","year":"2016","unstructured":"McAllister-Williams RH, Anderson IM, Finkelmeyer A, Gallagher P, Grunze HC, Haddad PM et al (2016) Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial. Lancet Psychiatry 3(2):117\u2013127","journal-title":"Lancet Psychiatry"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neubiorev.2014.07.005","volume":"45","author":"RJ McQuaid","year":"2014","unstructured":"McQuaid RJ, McInnis OA, Abizaid A, Anisman H (2014) Making room for oxytocin in understanding depression. Neurosci Biobehav Rev 45:305\u2013322","journal-title":"Neurosci Biobehav Rev"},{"issue":"10152","key":"1_CR98","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","volume":"392","author":"S Meltzer-Brody","year":"2018","unstructured":"Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR et al (2018) Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet 392(10152):1058\u20131070","journal-title":"Lancet"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fnmol.2018.00359","volume":"11","author":"AL Mendell","year":"2018","unstructured":"Mendell AL, MacLusky NJ (2018) Neurosteroid metabolites of gonadal steroid hormones in Neuroprotection: implications for sex differences in neurodegenerative disease. Front Mol Neurosci 11:359","journal-title":"Front Mol Neurosci"},{"key":"1_CR100","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fpsyt.2019.00101","volume":"10","author":"A Menke","year":"2019","unstructured":"Menke A (2019) Is the HPA Axis as target for depression outdated, or is there a new Hope? Front Psych 10:101","journal-title":"Front Psych"},{"issue":"12","key":"1_CR101","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1017\/S1092852900023944","volume":"14","author":"KK Miller","year":"2009","unstructured":"Miller KK, Perlis RH, Papakostas GI, Mischoulon D, Losifescu DV, Brick DJ et al (2009) Low-dose transdermal testosterone augmentation therapy improves depression severity in women. CNS Spectr 14(12):688\u2013694","journal-title":"CNS Spectr"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"104831","DOI":"10.1016\/j.psyneuen.2020.104831","volume":"122","author":"M-C Mokrani","year":"2020","unstructured":"Mokrani M-C, Duval F, Erb A, Gonzalez Lopera F, Danila V (2020) Are the thyroid and adrenal system alterations linked in depression? Psychoneuroendocrinology 122:104831","journal-title":"Psychoneuroendocrinology"},{"key":"1_CR103","volume-title":"General principles of endocrine physiology. Endocrine physiology","author":"PE Molina","year":"2013","unstructured":"Molina PE (2013a) General principles of endocrine physiology. Endocrine physiology, 4th edn. McGraw-Hill, New York","edition":"4"},{"key":"1_CR104","volume-title":"Thyroid gland. Endocrine physiology","author":"PE Molina","year":"2013","unstructured":"Molina PE (2013b) Thyroid gland. Endocrine physiology, 4th edn. The McGraw-Hill Companies, New York","edition":"4"},{"key":"1_CR105","volume-title":"Female reproductive system. Endocrine physiology","author":"PE Molina","year":"2013","unstructured":"Molina PE (2013c) Female reproductive system. Endocrine physiology, 4th edn. The McGraw-Hill Companies, New York","edition":"4"},{"key":"1_CR106","volume-title":"Male reproductive system. Endocrine physiology","author":"PE Molina","year":"2013","unstructured":"Molina PE (2013d) Male reproductive system. Endocrine physiology, 4th edn. The McGraw-Hill Companies, New York","edition":"4"},{"issue":"1","key":"1_CR107","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.121011","volume":"20","author":"Z Momayez Sanat","year":"2022","unstructured":"Momayez Sanat Z, Mohajeri-Tehrani MR (2022) Psychotic disorder as the first manifestation of Addison disease: a case report. Int J Endocrinol Metab 20(1):e121011","journal-title":"Int J Endocrinol Metab"},{"issue":"10","key":"1_CR108","doi-asserted-by":"publisher","first-page":"R408","DOI":"10.1016\/j.cub.2014.04.017","volume":"24","author":"P Monaghan","year":"2014","unstructured":"Monaghan P, Spencer KA (2014) Stress and life history. Curr Biol 24(10):R408\u2013RR12","journal-title":"Curr Biol"},{"issue":"3","key":"1_CR109","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/GRF.0b013e3181b5a395","volume":"52","author":"EL Moses-Kolko","year":"2009","unstructured":"Moses-Kolko EL, Berga SL, Kalro B, Sit DK, Wisner KL (2009) Transdermal estradiol for postpartum depression: a promising treatment option. Clin Obstet Gynecol 52(3):516\u2013529","journal-title":"Clin Obstet Gynecol"},{"issue":"12","key":"1_CR110","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.biopsych.2017.10.012","volume":"82","author":"JW Murrough","year":"2017","unstructured":"Murrough JW, Charney DS (2017) Corticotropin-releasing factor type 1 receptor antagonists for stress-related disorders: time to call it quits? Biol Psychiatry 82(12):858\u2013860","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1_CR111","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/07435800.2014.896924","volume":"40","author":"L Najafi","year":"2015","unstructured":"Najafi L, Malek M, Hadian A, Ebrahim Valojerdi A, Khamseh ME, Aghili R (2015) Depressive symptoms in patients with subclinical hypothyroidism\u2014the effect of treatment with levothyroxine: a double-blind randomized clinical trial. Endocr Res 40(3):121\u2013126","journal-title":"Endocr Res"},{"issue":"1","key":"1_CR112","first-page":"77","volume":"97","author":"RE Nappi","year":"2001","unstructured":"Nappi RE, Petraglia F, Luisi S, Polatti F, Farina C, Genazzani AR (2001) Serum allopregnanolone in women with postpartum \u201cblues\u201d. Obstet Gynecol 97(1):77\u201380","journal-title":"Obstet Gynecol"},{"key":"1_CR113","unstructured":"NICE (2022) Depression in adults: treatment and management (NG222). https:\/\/www.nice.org.uk\/guidance\/ng222"},{"key":"1_CR114","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jad.2021.12.134","volume":"302","author":"NA Nu\u00f1ez","year":"2022","unstructured":"Nu\u00f1ez NA, Joseph B, Pahwa M, Kumar R, Resendez MG, Prokop LJ et al (2022) Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis. J Affect Disord 302:385\u2013400","journal-title":"J Affect Disord"},{"key":"1_CR115","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.psyneuen.2017.02.012","volume":"79","author":"LM Osborne","year":"2017","unstructured":"Osborne LM, Gispen F, Sanyal A, Yenokyan G, Meilman S, Payne JL (2017) Lower allopregnanolone during pregnancy predicts postpartum depression: an exploratory study. Psychoneuroendocrinology 79:116\u2013121","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"1_CR116","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1017\/S0033291719001454","volume":"49","author":"EF Osimo","year":"2019","unstructured":"Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM (2019) Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med 49(12):1958\u20131970","journal-title":"Psychol Med"},{"key":"1_CR117","first-page":"2270202","volume":"2022","author":"BA Pallant","year":"2022","unstructured":"Pallant BA, Moore CE, Topor LS (2022) Clinical thyrotoxicosis resulting from liothyronine augmentation of antidepressant therapy in an adolescent. Case Rep Psychiatry 2022:2270202","journal-title":"Case Rep Psychiatry"},{"issue":"5","key":"1_CR118","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0006-3223(00)01088-X","volume":"49","author":"CM Pariante","year":"2001","unstructured":"Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49(5):391\u2013404","journal-title":"Biol Psychiatry"},{"issue":"12","key":"1_CR119","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1002\/jnr.24721","volume":"98","author":"C Peixoto","year":"2020","unstructured":"Peixoto C, Jos\u00e9 Grande A, Gomes Carrilho C, Egidio NA, Cardoso A, Barciela VA (2020) Dehydroepiandrosterone for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. J Neurosci Res 98(12):2510\u20132528","journal-title":"J Neurosci Res"},{"issue":"5","key":"1_CR120","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s11102-022-01262-8","volume":"25","author":"R Pivonello","year":"2022","unstructured":"Pivonello R, Simeoli C, Di Paola N, Colao A (2022) Cushing\u2019s disease: adrenal steroidogenesis inhibitors. Pituitary 25(5):726\u2013732","journal-title":"Pituitary"},{"issue":"5","key":"1_CR121","doi-asserted-by":"publisher","first-page":"25502","DOI":"10.3402\/jchimp.v4.25502","volume":"4","author":"RR Poudel","year":"2014","unstructured":"Poudel RR, Belbase B, Belbase B, Kafle NK (2014) Apathetic thyrotoxicosis presenting with diabetes mellitus. J Commun Hosp Intern Med Perspect 4(5):25502","journal-title":"J Commun Hosp Intern Med Perspect"},{"issue":"6","key":"1_CR122","doi-asserted-by":"publisher","first-page":"101367","DOI":"10.1016\/j.beem.2019.101367","volume":"33","author":"F Ragusa","year":"2019","unstructured":"Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo SR, Giusti C et al (2019) Hashimotos\u2019 thyroiditis: epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab 33(6):101367","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1_CR123","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/OAJC.S183193","volume":"10","author":"AJ Rapkin","year":"2019","unstructured":"Rapkin AJ, Korotkaya Y, Taylor KC (2019) Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives. Open Access J Contracept 10:27\u201339","journal-title":"Open Access J Contracept"},{"key":"1_CR124","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","volume":"186","author":"DS Reddy","year":"2010","unstructured":"Reddy DS (2010) Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 186:113\u2013137","journal-title":"Prog Brain Res"},{"issue":"2","key":"1_CR125","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1590\/S0004-27302012000200006","volume":"56","author":"VS Reuters","year":"2012","unstructured":"Reuters VS, Almeida Cde P, Teixeira Pde F, Vig\u00e1rio Pdos S, Ferreira MM, Castro CL et al (2012) Effects of subclinical hypothyroidism treatment on psychiatric symptoms, muscular complaints, and quality of life. Arq Bras Endocrinol Metabol 56(2):128\u2013136","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"6","key":"1_CR126","first-page":"849","volume":"56","author":"Z Rog\u00f3z","year":"2004","unstructured":"Rog\u00f3z Z, Skuza G, W\u00f3jcikowski J, Daniel WA, Wr\u00f3bel A, Dudek D et al (2004) Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression. Pol J Pharmacol 56(6):849\u2013855","journal-title":"Pol J Pharmacol"},{"issue":"10","key":"1_CR127","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1176\/appi.ajp.2011.10030402","volume":"168","author":"LJ Rosenthal","year":"2011","unstructured":"Rosenthal LJ, Goldner WS, O\u2019Reardon JP (2011) T3 augmentation in major depressive disorder: safety considerations. Am J Psychiatr 168(10):1035\u20131040","journal-title":"Am J Psychiatr"},{"issue":"5","key":"1_CR128","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_561_21","volume":"64","author":"MK Sahu","year":"2022","unstructured":"Sahu MK, Dubey RK, Chandrakar A, Kumar M, Kumar M (2022) A systematic review and meta-analysis of serum and plasma cortisol levels in depressed patients versus control. Indian J Psychiatry 64(5):440\u2013448","journal-title":"Indian J Psychiatry"},{"issue":"3","key":"1_CR129","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/MED.0000000000000633","volume":"28","author":"A Santos","year":"2021","unstructured":"Santos A, Webb SM, Resmini E (2021) Psychological complications of Cushing\u2019s syndrome. Curr Opin Endocrinol Diabetes Obes 28(3):325\u2013329","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"1_CR130","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s43440-022-00377-w","volume":"74","author":"N Sawicka-Gutaj","year":"2022","unstructured":"Sawicka-Gutaj N, Zawalna N, Gut P, Rucha\u0142a M (2022) Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions. Pharmacol Rep 74(5):847\u2013858","journal-title":"Pharmacol Rep"},{"key":"1_CR131","volume-title":"Schatzberg\u2019s manual of clinical psychopharmacology","author":"AF Schatzberg","year":"2024","unstructured":"Schatzberg AF, DeBattista C (2024) Augmentation strategies for treatment-resistant disorders. In: Schatzberg\u2019s manual of clinical psychopharmacology. American Psychiatric Association, Washington, DC"},{"issue":"1","key":"1_CR132","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1017\/S1092852914000480","volume":"20","author":"CE Schiller","year":"2015","unstructured":"Schiller CE, Meltzer-Brody S, Rubinow DR (2015) The role of reproductive hormones in postpartum depression. CNS Spectr 20(1):48\u201359","journal-title":"CNS Spectr"},{"issue":"10","key":"1_CR133","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1176\/appi.ajp.2017.16101113","volume":"174","author":"PJ Schmidt","year":"2017","unstructured":"Schmidt PJ, Martinez PE, Nieman LK, Koziol DE, Thompson KD, Schenkel L et al (2017) Premenstrual dysphoric disorder symptoms following ovarian suppression: triggered by change in ovarian steroid levels but not continuous stable levels. Am J Psychiatry 174(10):980\u2013989","journal-title":"Am J Psychiatry"},{"issue":"11","key":"1_CR134","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/brainsci12111540","volume":"12","author":"A Seshadri","year":"2022","unstructured":"Seshadri A, Sundaresh V, Prokop LJ, Singh B (2022) Thyroid hormone augmentation for bipolar disorder: a systematic review. Brain Sci 12(11):1540","journal-title":"Brain Sci"},{"issue":"6","key":"1_CR135","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamapsychiatry.2018.0190","volume":"75","author":"EM Siegmann","year":"2018","unstructured":"Siegmann EM, M\u00fcller HHO, Luecke C, Philipsen A, Kornhuber J, Gr\u00f6mer TW (2018) Association of depression and anxiety disorders with autoimmune thyroiditis: a systematic review and meta-analysis. JAMA Psychiatry 75(6):577\u2013584","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"1_CR136","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s40263-023-01030-7","volume":"37","author":"C Sikes-Keilp","year":"2023","unstructured":"Sikes-Keilp C, Rubinow DR (2023) GABA-ergic modulators: new therapeutic approaches to premenstrual dysphoric disorder. CNS Drugs 37(8):679\u2013693","journal-title":"CNS Drugs"},{"issue":"11","key":"1_CR137","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamapsychiatry.2016.2387","volume":"73","author":"CW Skovlund","year":"2016","unstructured":"Skovlund CW, M\u00f8rch LS, Kessing LV, Lidegaard \u00d8 (2016) Association of hormonal contraception with depression. JAMA Psychiatry 73(11):1154\u20131162","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"1_CR138","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/thy.2022.0304","volume":"33","author":"S Soheili-Nezhad","year":"2023","unstructured":"Soheili-Nezhad S, Sprooten E, Tendolkar I, Medici M (2023) Exploring the genetic link between thyroid dysfunction and common psychiatric disorders: a specific hormonal or a general autoimmune comorbidity. Thyroid 33(2):159\u2013168","journal-title":"Thyroid"},{"issue":"10","key":"1_CR139","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1517\/13543784.2012.711314","volume":"21","author":"V Srinivasan","year":"2012","unstructured":"Srinivasan V, De Berardis D, Shillcutt SD, Brzezinski A (2012) Role of melatonin in mood disorders and the antidepressant effects of agomelatine. Expert Opin Investig Drugs 21(10):1503\u20131522","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"1_CR140","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/jcm10040784","volume":"10","author":"R Strawbridge","year":"2021","unstructured":"Strawbridge R, Jamieson A, Hodsoll J, Ferrier IN, McAllister-Williams RH, Powell TR et al (2021) The role of inflammatory proteins in anti-glucocorticoid therapy for treatment-resistant depression. J Clin Med 10(4):784","journal-title":"J Clin Med"},{"issue":"1","key":"1_CR141","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12888-023-04519-z","volume":"23","author":"J Sun","year":"2023","unstructured":"Sun J, Qiu L, Zhang H, Zhou Z, Ju L, Yang J (2023) CRHR1 antagonist alleviates LPS-induced depression-like behaviour in mice. BMC Psychiatry 23(1):17","journal-title":"BMC Psychiatry"},{"key":"1_CR142","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fendo.2019.00340","volume":"10","author":"R Tang","year":"2019","unstructured":"Tang R, Wang J, Yang L, Ding X, Zhong Y, Pan J et al (2019) Subclinical hypothyroidism and depression: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 10:340","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1_CR143","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/0006-3223(94)00137-R","volume":"37","author":"JH Thakore","year":"1995","unstructured":"Thakore JH, Dinan TG (1995) Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry 37(6):364\u2013368","journal-title":"Biol Psychiatry"},{"key":"1_CR144","doi-asserted-by":"publisher","first-page":"104793","DOI":"10.1016\/j.psyneuen.2020.104793","volume":"120","author":"TA Thul","year":"2020","unstructured":"Thul TA, Corwin EJ, Carlson NS, Brennan PA, Young LJ (2020) Oxytocin and postpartum depression: a systematic review. Psychoneuroendocrinology 120:104793","journal-title":"Psychoneuroendocrinology"},{"issue":"3\u20134","key":"1_CR145","first-page":"24","volume":"14","author":"KTB Touma","year":"2017","unstructured":"Touma KTB, Zoucha AM, Scarff JR (2017) Liothyronine for depression: a review and guidance for safety monitoring. Innov Clin Neurosci 14(3\u20134):24\u201329","journal-title":"Innov Clin Neurosci"},{"key":"1_CR146","doi-asserted-by":"publisher","first-page":"115316","DOI":"10.1016\/j.psychres.2023.115316","volume":"326","author":"P-T Tseng","year":"2023","unstructured":"Tseng P-T, Chiu H-J, Suen M-W, Zeng B-S, Wu M-K, Tu Y-K et al (2023) Pharmacological interventions and hormonal therapies for depressive symptoms in peri- and post-menopausal women: a network meta-analysis of randomized controlled trials. Psychiatry Res 326:115316","journal-title":"Psychiatry Res"},{"key":"1_CR147","unstructured":"U.S. Food and Drug Administration (2019a) Information about drosperinone. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/information-about-drospirenone"},{"key":"1_CR148","unstructured":"U.S. Food and Drug Administration (2019b) FDA approves first treatment for post-partum depression. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-post-partum-depression"},{"key":"1_CR149","unstructured":"U.S. Food and Drug Administration (2023) FDA approves first oral treatment for postpartum depression. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-oral-treatment-postpartum-depression"},{"issue":"11","key":"1_CR150","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/ph16111572","volume":"16","author":"CM Vecera","year":"2023","unstructured":"Vecera CM, Courtes AC, Jones G, Soares JC, Machado-Vieira R (2023) Pharmacotherapies targeting GABA-glutamate neurotransmission for treatment-resistant depression. Pharmaceuticals (Basel) 16(11):1572","journal-title":"Pharmaceuticals (Basel)"},{"key":"1_CR151","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajp.2013.12.004","volume":"8","author":"G Vishnoi","year":"2014","unstructured":"Vishnoi G, Chakraborty B, Garda H, Gowda SH, Goswami B (2014) Low mood and response to levothyroxine treatment in Indian patients with subclinical hypothyroidism. Asian J Psychiatr 8:89\u201393","journal-title":"Asian J Psychiatr"},{"issue":"4","key":"1_CR152","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22r14614","volume":"84","author":"M Wagner-Schuman","year":"2023","unstructured":"Wagner-Schuman M, Kania A, Barone JC, Ross JM, Mulvihill A, Eisenlohr-Moul TA (2023) What\u2019s stopping us? Using GnRH analogs with stable hormone addback in treatment-resistant premenstrual dysphoric disorder: practical guidelines and risk-benefit analysis for long-term therapy. J Clin Psychiatry 84(4):22r14614","journal-title":"J Clin Psychiatry"},{"key":"1_CR153","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.2147\/DDDT.S240856","volume":"15","author":"A Walkery","year":"2021","unstructured":"Walkery A, Leader LD, Cooke E, VandenBerg A (2021) Review of allopregnanolone agonist therapy for the treatment of depressive disorders. Drug Des Devel Ther 15:3017\u20133026","journal-title":"Drug Des Devel Ther"},{"key":"1_CR154","volume-title":"FDA approves first treatment for post-partum depression","author":"S Walsh","year":"2019","unstructured":"Walsh S (2019) FDA approves first treatment for post-partum depression. FDA, Silver Spring, MD"},{"issue":"1","key":"1_CR155","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/jamapsychiatry.2018.2734","volume":"76","author":"A Walther","year":"2019","unstructured":"Walther A, Breidenstein J, Miller R (2019) Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis. JAMA Psychiatry 76(1):31\u201340","journal-title":"JAMA Psychiatry"},{"key":"1_CR156","doi-asserted-by":"publisher","first-page":"105327","DOI":"10.1016\/j.neubiorev.2023.105327","volume":"152","author":"NL Walton","year":"2023","unstructured":"Walton NL, Antonoudiou P, Maguire JL (2023) Neurosteroid influence on affective tone. Neurosci Biobehav Rev 152:105327","journal-title":"Neurosci Biobehav Rev"},{"issue":"11","key":"1_CR157","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.biopsych.2012.05.029","volume":"72","author":"S Watson","year":"2012","unstructured":"Watson S, Gallagher P, Porter RJ, Smith MS, Herron LJ, Bulmer S et al (2012) A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biol Psychiatry 72(11):943\u2013949","journal-title":"Biol Psychiatry"},{"key":"1_CR158","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fnmol.2018.00216","volume":"11","author":"ME Watts","year":"2018","unstructured":"Watts ME, Pocock R, Claudianos C (2018) Brain energy and oxygen metabolism: emerging role in normal function and disease. Front Mol Neurosci 11:216","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"1_CR159","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1176\/ajp.150.5.810","volume":"150","author":"OM Wolkowitz","year":"1993","unstructured":"Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H (1993) Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry 150(5):810\u2013812","journal-title":"Am J Psychiatry"},{"issue":"8","key":"1_CR160","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S0006-3223(98)00267-4","volume":"45","author":"OM Wolkowitz","year":"1999","unstructured":"Wolkowitz OM, Reus VI, Chan T, Manfredi F, Raum W, Johnson R et al (1999) Antiglucocorticoid treatment of depression: double-blind ketoconazole. Biol Psychiatry 45(8):1070\u20131074","journal-title":"Biol Psychiatry"},{"issue":"6","key":"1_CR161","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","volume":"111","author":"KM Wyatt","year":"2004","unstructured":"Wyatt KM, Dimmock PW, Ismail KMK, Jones PW, O\u2019Brien PMS (2004) The effectiveness of GnRHa with and without \u2018add-back\u2019 therapy in treating premenstrual syndrome: a meta analysis. BJOG Int J Obstet Gynaecol 111(6):585\u2013593","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"1_CR162","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-981-10-6580-4_24","volume-title":"Understanding depression: volume 1 biomedical and neurobiological background","author":"S Yoon","year":"2018","unstructured":"Yoon S, Kim Y-K (2018) Gender differences in depression. In: Kim Y-K (ed) Understanding depression: volume 1 biomedical and neurobiological background. Springer, Singapore, pp 297\u2013307"},{"key":"1_CR163","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-981-32-9705-0_7","volume":"1191","author":"S Yoon","year":"2020","unstructured":"Yoon S, Kim YK (2020) The role of the oxytocin system in anxiety disorders. Adv Exp Med Biol 1191:103\u2013120","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"1_CR164","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194773","volume":"13","author":"S Zettermark","year":"2018","unstructured":"Zettermark S, Perez Vicente R, Merlo J (2018) Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: a pharmacoepidemiological study on 800 000 Swedish women. PLoS One 13(3):e0194773","journal-title":"PLoS One"},{"key":"1_CR165","doi-asserted-by":"publisher","first-page":"950004","DOI":"10.3389\/fphar.2022.950004","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Dai X, Li W (2022) Comparative efficacy and acceptability of pharmacotherapies for postpartum depression: a systematic review and network meta-analysis. Front Pharmacol 13:950004","journal-title":"Front Pharmacol"},{"key":"1_CR166","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jpsychires.2023.04.002","volume":"162","author":"J Zhang","year":"2023","unstructured":"Zhang J, Yin J, Song X, Lai S, Zhong S, Jia Y (2023) The effect of exogenous estrogen on depressive mood in women: a systematic review and meta-analysis of randomized controlled trials. J Psychiatr Res 162:21\u201329","journal-title":"J Psychiatr Res"},{"issue":"6","key":"1_CR167","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/andr.12867","volume":"8","author":"M Zitzmann","year":"2020","unstructured":"Zitzmann M (2020) Testosterone, mood, behaviour and quality of life. Andrology 8(6):1598\u20131605","journal-title":"Andrology"},{"issue":"3","key":"1_CR168","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0022-3956(00)00016-9","volume":"34","author":"AW Zobel","year":"2000","unstructured":"Zobel AW, Nickel T, K\u00fcnzel HE, Ackl N, Sonntag A, Ising M et al (2000) Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res 34(3):171\u2013181","journal-title":"J Psychiatr Res"}],"container-title":["Advances in Experimental Medicine and Biology","Recent Advances and Challenges in the Treatment of Major Depressive Disorder"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-97-4402-2_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T02:03:27Z","timestamp":1726106607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-97-4402-2_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9789819744015","9789819744022"],"references-count":168,"URL":"https:\/\/doi.org\/10.1007\/978-981-97-4402-2_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"13 September 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}